Maternal Mental Health Market Size is valued at USD 6.36 Bn in 2022 and is predicted to reach USD 52.28 Bn by the year 2031 at a 26.5% CAGR during the forecast period for 2023-2031.
The maternal mental health market is a subset of the healthcare business that focuses on diagnosing, treating, and preventing mental health disorders in pregnant women and new mothers. Perinatal depression and anxiety, as well as postpartum depression and psychosis, are examples of mental health concerns. As medical professionals, decision-makers, and the general public become more aware of the frequency and repercussions of mental health disorders during pregnancy and postpartum, there has been an increasing recognition of the importance of maternal mental health. This growing understanding has resulted in significant commercial advances, particularly in incorporating technology in healthcare services. Telehealth, digital health, and mobile applications have revolutionized the ease with which pregnant women and new moms may access mental health care and support.
However, the pandemic of COVID-19 has had a significant influence on the maternal mental health industry, affecting pregnant women and new moms all over the world. The pandemic introduced new obstacles that exacerbated existing mental health issues and created new ones, resulting in a unique and complex scenario for mother mental health. Pregnant women and new mothers have suffered heightened stress and anxiety as a result of the pandemic. Uncertainty and fear about the virus's influence on their health and their children's health, combined with economic and social disturbances, have taken a toll on their mental health.
Competitive Landscape
Some Major Key Players In The Maternal Mental Health Market:
- Therapy Mama
- Canopie
- Pfizer Inc
- Viatris Inc.
- GlaxoSmithKline Inc.
- Alembic Pharmaceuticals Limited
- Mallinckrodt Inc.
- Sage Therapeutics, Inc.
- Bausch Health Companies Inc.
- Magellan Health, Inc.
- Happify Health
- Sonder Mind
- Maven Clinic
- Wildflower Health
- Hims and Hers
- Medela LLC
- Clue
- Happy Mom
- Postpartum Support International
- Others
Market Segmentation:
The Maternal Mental Health Market is segmented on the basis of disease indication and therapy. According to disease indication, the market is segmented as Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, and Others. The therapy segment includes Antidepressants, Selective serotonin reuptake inhibitors (SSRIs), Tricyclic antidepressants (TCAs), Interpersonal Psychotherapy (IPT), Cognitive Behavioral Therapy (CBT), and Others.
Based On Disease Indication, The Pregnancy And Postpartum OCD Segment Is Accounted As A Major Contributor To The Maternal Mental Health Market
The Pregnancy and Postpartum OCD category is expected to hold a major share in the global Maternal Mental Health Market in 2022. Postpartum depression is a well known and common mental health issue that affects women after childbirth, accounting for a sizable portion of the maternal mental health market. As awareness has grown, more women are seeking help and therapy. Healthcare providers and advocacy groups place a premium on early detection and intervention. Telehealth and digital health solutions are critical for providing remote counselling and assistance. The incorporation of mental health services within maternity care settings improves access to specialized care.
Interpersonal Psychotherapy (IPT) Segment Witnessed Growth At A Rapid Rate
The Interpersonal Psychotherapy (IPT)segment is projected to grow rapidly in the global Maternal Mental Health Market. Interpersonal psychotherapy, which focuses on improving relationships and addressing the causes contributing to a mother's mental health issues, is an important treatment method in the maternal mental health market. IPT assists expecting and new moms in navigating the common perinatal tensions, role shifts, and life changes. It promotes emotional well-being through improving coping mechanisms and communication. IPT, which provides structured and time-limited psychotherapy, is extremely useful for women suffering from postpartum depression or anxiety.
In The Region, The North America Maternal Mental Health Market Holds A Significant Revenue Share
The North America Maternal Mental Health Market is expected to record the maximum market share in revenue in the near future. Increased awareness, well-established healthcare systems, and government programs encouraging maternal mental health help the area.
Technology improvements like telehealth and increased access to healthcare services help pregnant women and new mothers manage their mental health. Due to a number of factors, such as a lack of facilities providing super-speciality care, parents' increased willingness to consult super-specialists, the growing popularity of the region's established healthcare infrastructure, and ongoing investigations for the development of cutting-edge technologies and services, Asia Pacific is estimated to grow significantly.
Recent Developments:
- In February 2023, Biogen Inc. and Sage Therapeutics, Inc. announced that the US Food & Drug Administration has accepted zuranolone's New Drug Application for treating PPD and major depressive disorder. The claim has been granted priority review, and the FDA has assigned an August 5, 2023, Prescription Drug User Fee Act action date.
Maternal Mental Health Market Report Scope:
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 6.36 Bn |
|
Revenue Forecast In 2031 |
USD 52.28 Bn |
|
Growth Rate CAGR |
CAGR of 26.5% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Disease Indication, By Therapy |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Therapy Mama, Canopie, Pfizer Inc., Viatris Inc., GlaxoSmithKline Inc., Alembic Pharmaceuticals Limited, Mallinckrodt Inc., Sage Therapeutics, Inc., Bausch Health Companies Inc., and Magellan Health, Inc., Happify Health, Sonder Mind, Maven Clinic, Wildflower Health, Hims and Hers, Medela LLC, Clue, Happy Mom, Postpartum Support International, and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
